Biolab Sanus Farmacêutica Ltda.’s Acquisition of Actavis Farmacêutica Ltda.


Felsberg advised on the deal

Biolab Sanus Farmacêutica Ltda. finalized the acquisition of Actavis Farmacêutica Ltda. from Teva Farmacêutica Ltda. – operating as a subsidiary of Teva Pharmaceutical Industries Ltd. and Actavis Dutch Holding B.V. – for an undisclosed ammount.

Biolab Sanus Farmaceutica Ltda., a pharmaceutical company, develops, manufactures, and commercializes prescription medicines in the areas of cardiology, rheumatology, orthopedics, general practice, pediatrics, endocrinology, geriatrics, and dermatology. The company is based in Sao Paulo.

Felsberg Advogados advised Teva Farmacêutica Ltda. and Actavis Dutch Holding B.V. with Claudia Maniaci (Picture), Carolina Guazzelli, Lucas von Wieser Ruggeri and Andrea de Barros Filomeno Faria.

Involved fees earner: Claudia Maniaci – Felsberg Advogados; María Carolina De Souza Guazzelli – Felsberg Advogados; Lucas von Wieser Ruggeri – Felsberg Advogados; Andrea de Barros Filomeno Faria – Felsberg Advogados;

Law Firms: Felsberg Advogados;

Clients: Actavis Dutch Holding B.V.; Teva Farmacêutica Ltda. ;

Avatar

Author: Ambrogio Visconti.